Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ASCIA Guideline: Infant Feeding for Food Allergy Prevention.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same author

Still a 'boys' club': a qualitative analysis of how gender affects a career in anaesthesia in Australia and Aotearoa New Zealand.

Anaesthesia·2024
Same author

Successful return to work in anaesthesia after maternity leave: a qualitative study.

Anaesthesia·2024
Same author

The first report of macrocyclic lactone resistant cyathostomins in the UK.

International journal for parasitology. Drugs and drug resistance·2023
Same author

Inspiratory muscle training for the treatment of dynamic upper airway collapse in racehorses: A preliminary investigation.

Veterinary journal (London, England : 1997)·2021
Same author

Effect of inclusion or exclusion of epithelial cells in equine respiratory cytology analysis.

Veterinary journal (London, England : 1997)·2019

Related Experiment Video

Updated: May 9, 2026

A Treatment Package without Escape Extinction to Address Food Selectivity
04:23

A Treatment Package without Escape Extinction to Address Food Selectivity

Published on: August 21, 2015

Optimal timing for solids introduction - why are the guidelines always changing?

J J Koplin1, K J Allen

  • 1Murdoch Childrens Research Institute, The Royal Children's Hospital, Melbourne, Australia.

Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|July 30, 2013
PubMed
Summary

Infant feeding guidelines for introducing solids and allergenic foods have changed significantly over decades. Current recommendations vary, highlighting the need for evidence-based updates to inform public health practices.

More Related Videos

Non-Nutritive Suck Parameters Measurements Using a Custom Pressure Transducer System
06:19

Non-Nutritive Suck Parameters Measurements Using a Custom Pressure Transducer System

Published on: April 19, 2024

Related Experiment Videos

Last Updated: May 9, 2026

A Treatment Package without Escape Extinction to Address Food Selectivity
04:23

A Treatment Package without Escape Extinction to Address Food Selectivity

Published on: August 21, 2015

Non-Nutritive Suck Parameters Measurements Using a Custom Pressure Transducer System
06:19

Non-Nutritive Suck Parameters Measurements Using a Custom Pressure Transducer System

Published on: April 19, 2024

Area of Science:

  • Pediatrics
  • Immunology
  • Public Health Nutrition

Background:

  • Infant feeding practices, particularly the timing of solid food introduction, have evolved dramatically over the past 40 years.
  • The age of weaning and introduction of allergenic foods are suspected factors in food allergy development, but evidence remains inconsistent.

Purpose of the Study:

  • To review the historical evolution of infant feeding guidelines regarding the introduction of solids and allergenic foods.
  • To examine the evidence supporting current recommendations and highlight the existing clinical equipoise.

Main Methods:

  • Historical analysis of infant feeding guidelines from the 1960s to the present.
  • Review of scientific literature on the relationship between timing of food introduction and food allergy development.
  • Comparative analysis of recent international guidelines (UK, US, Australia).

Main Results:

  • Guidelines shifted from early solid introduction (pre-4 months) to delayed introduction (post-6 months).
  • Significant controversy and inconsistent recommendations exist regarding the optimal timing for introducing solids and allergenic foods.
  • Recent guidelines from major countries show convergence but still reflect clinical equipoise.

Conclusions:

  • Modifying infant feeding guidelines requires a thorough review of emerging research to establish a robust evidence base.
  • Future guidelines must address both high-risk and general infant populations for optimal public health practice.
  • Continued research is crucial to resolve inconsistencies in infant feeding recommendations and food allergy prevention.